>20 years experience in market intelligence, analytics and similar strategic positions like sales force excellence, competitive intelligence and forecasting, predominantly in the pharmaceutical industry, > 10 years of which in senior positions. Leadership experience in teams up to 15. Fluency in English, good command of the French language. Intercultural experience.

Leadership experience in teams up to 15 with proven ability to create loyalty and buy-in in teams.

Areas of experience: Market intelligence with a strong interest in developing tools and methods. Data science, forecasting, modeling, predictive analytics, business intelligence, competitive intelligence. More than basic understanding of software engineering, R, SQL, Python, JavaScript.

Well-established strategic advisor to corporate leaders on seizing business opportunities and pre-empting potential threats. Extensive experience in managing strategic projects for senior management. Frequent speaker at conferences on using scenarios/early-warning systems for risk management and strategic decision-making.

Currently working as a senior oncology consultant for top-10 pharma companies worldwide and have expertise in market research and landscaping. Additionally, I have ~8 years of pre- and post-doctoral research experience in the medicinal chemistry discipline and have authored three scientific publications in peer-reviewed scientific journals.

We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Our products and services are designed to benefit people and improve their quality of life. At the same time, we aim to create value through innovation, growth and high earning power. Our products help address some of today’s biggest challenges, including global population growth, an aging society and the need to make efficient – and, wherever possible, sustainable – use of natural resources. In line with our mission “Bayer: Science For A Better Life,” we aim to improve people’s quality of life by preventing, alleviating or curing diseases. We also help provide an adequate supply of high-quality food, feed and renewable plant-based raw materials. For these endeavors, we focus on developing and successfully commercializing innovative products and solutions based on scientific knowledge.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI).

Fenix Group International, LLC, known as FGI Life Sciences outside the US and Switzerland, is a global life sciences consulting firm established in 2015. From our inception, there was a distinct belief that life science consulting firms absent a technology offering will eventually become obsolete. Led by President Matthew Maryniak, our team of 100+ employees integrates cutting-edge technology created by FENIX Labs, our in-house software engineering team, with world-class management consulting. Services include market intelligence, strategic workshops, and custom technology builds that incorporate machine learning and natural language processing. In 2022, we surpassed $10M in top-line revenue for the first time, achieving a 7-year CAGR of 35% - 3.5x above the average in life sciences services. See all that we have to offer at www.fenix.group.